„Tato webová stránka obsahuje obecné informace o stravě, zdraví a výživě. Veškeré informace uvedené na této webové stránce, jakož i informace, které jsou prostřednictvím této webové stránky poskytovány, slouží pouze ke vzdělávacím účelům. Tyto informace nelze brát jako odborné rady, ani s nimi tak zacházet.
Sērum s.r.o. ve vztahu k informacím o zdraví, uvedeným na této webové stránce, neposkytuje žádné záruky. Nesmíte se spoléhat na informace, uvedené na této webové stránce, jako na alternativu rady od svého lékaře nebo jiného odborníka poskytujícího zdravotnickou péči.
Sērum s.r.o. nemůže nést odpovědnost za jakékoliv nevhodné či nesprávné využití informací či služeb poskytovaných touto webovou stránkou a zříká se jakékoliv odpovědnosti za jakékoliv využití informací či služeb zde poskytovaných.“
Veškeré informace uvedené na webu www.serum.cz ve vztahu k účinným látkám v BRAIN BALANCE, byly čerpány ze zdrojů, které naleznete níže.
Egashira, N., Ishigami, N., Pu, F., Mishima, K., Iwasaki, K., Orito, K., Oishi, R., and Fujiwara, M. Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. Phytother.Res 2008;22(1):65-68. View abstract.
Giesbrecht, T., Rycroft, J. A., Rowson, M. J., and De Bruin, E. A. The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness. Nutr Neurosci. 2010;13(6):283-290. View abstract.
Haskell, C. F., Kennedy, D. O., Milne, A. L., Wesnes, K. A., and Scholey, A. B. The effects of L-theanine, caffeine and their combination on cognition and mood. Biol.Psychol. 2008;77(2):113-122. View abstract.
Kakuda, T. Neuroprotective effects of the green tea components theanine and catechins. Biol Pharm Bull 2002;25(12):1513-1518. View abstract.
Kakuda, T., Nozawa, A., Sugimoto, A., and Niino, H. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors. Biosci.Biotechnol.Biochem. 2002;66(12):2683-2686. View abstract.
Kamath, A. B., Wang, L., Das, H., Li, L., Reinhold, V. N., and Bukowski, J. F. Antigens in tea-beverage prime .
Studie n
human Vgamma 2Vdelta 2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses. Proc Natl.Acad.Sci U.S.A 5-13-2003;100(10):6009-6014. View abstract.
Kimura, K., Ozeki, M., Juneja, L. R., and Ohira, H. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007;74(1):39-45. View abstract.
Matsumoto, K., Yamada, H., Takuma, N., Niino, H., and Sagesaka, Y. M. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC.Complement Altern.Med. 2011;11:15. View abstract.
Rogers, P. J., Smith, J. E., Heatherley, S. V., and Pleydell-Pearce, C. W. Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology (Berl) 2008;195(4):569-577. View abstract.
Sadzuka, Y., Sugiyama, T., Suzuki, T., and Sonobe, T. Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol.Lett 9-15-2001;123(2-3):159-167. View abstract.
Sugiyama, T. and Sadzuka, Y. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents. Biochim.Biophys.Acta 12-5-2003;1653(2):47-59. View abstract.
Sugiyama, T. and Sadzuka, Y. Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett. 8-30-2004;212(2):177-184. View abstract.
Sugiyama, T., Sadzuka, Y., Nagasawa, K., Ohnishi, N., Yokoyama, T., and Sonobe, T. Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin. Jpn J Cancer Res 1999;90(7):775-780. View abstract.
Terashima, T., Takido, J., and Yokogoshi, H. Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci.Biotechnol.Biochem. 1999;63(4):615-618. View abstract.
Yang, Q. S., Xu, P. X., Li, Y. H., Jiang, S., Zhang, X., and Xue, M. [Effects of theanine and houpu extract in 7-day chick social separation-stress procedure]. Zhongguo Zhong.Yao Za Zhi. 2007;32(19):2040-2043. View abstract.
Yokogoshi, H., Kato, Y., Sagesaka, Y. M., Takihara-Matsuura, T., Kakuda, T., and Takeuchi, N. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci.Biotechnol.Biochem. 1995;59(4):615-618. View abstract.
Camfield DA, Stough C, Farrimond J, Scholey AB. Actue effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis. Nutr Rev. 2014;72(8):507-522. View abstract.
Dodd FL, Kennedy DO, Riby LM, Haskell-Ramsay CF. A double-blind, placebo-controlled study evaluating the effects of caffeine and L-theanine both alone and in combination on cerebral blood flow, cognition and mood. Psychopharmacology. 2015;232(14):2563-2576. View abstract.
Einöther SJ, Martens VE, Rycroft JA, De Bruin EA. L-theanine and caffeine improve task switching but not intersensory attention or subjective alertness. Appetite 2010;54(2):406-9. View abstract.
Foxe JJ, et al. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task. Neuropharmacology. 2012;62(7):2320-2327. View abstract.
Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-50. View abstract.
Hamaguchi R, Tsuchiya T, Miyata G, et al. Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03). Support Care Cancer. 2019. View abstract.
Hidese S, Ogawa S, Ota M, et al. Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults: A randomized controlled trial. Nutrients. 2019;11(10). pii: E2362. View abstract.
Hidese S, Ota M, Wakabayashi C, et al. Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study. Acta Neuropsychiatr 2017;29(2):72-9. View abstract.
Kahathuduwa CN, Dassanayake TL, Amarakoon AMT, Weerasinghe VS. effects of theanine, caffeine and theanine-caffeine combination on attention. Nutr Neurosci 2017;20(6):369-77. View abstract.
Kahathuduwa CN, Wakefield S, West BD, et al. Effects of L-theanine-caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT. Sci Rep 2020;10(1):13072. View abstract.
Kakuda T, Nozawa A, Unno T, et al. Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem 2000;64:287-93. View abstract.
Kakuda T, Yanase H, Utsunomiya K, et al. Protective effect of gamma-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils. Neurosci Lett 2000;289:189-92. View abstract.
Kardashev A, Ratner Y, Ritsner MS.Add-on pregnenolone with L-theanine to antipsychotic therapy relieves negative and anxiety symptoms of schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial. Clin Schizophr Relat Psychoses. 2018;12(1):31-41. doi: 10.3371/CSRP.KARA.070415. View abstract.
Kawada S, Kobayashi K, Ohtani M, Fukusaki C. Cystine and theanine supplementation restores high-intensity resistance exercise-induced attenuation of natural killer cell activity in well-trained men. J Strength Cond Res 2010;24(3):846-51. View abstract.
Kelly SP, Gomez-Ramirez M, Montesi JL, Foxe JJ. L-theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr 2008;138(8):1572S-1577S. View abstract.
Kimura R, Murata T. Effect of theanine on norepinephrine and serotonin levels in rat brain. Chem Pharm Bull 1986;34:3053-57.
Lin L, Zeng L, Liu A, et al. L-theanine regulates glucose, lipid, and protein metabolism via insulin and AMP-activated protein kinase signaling pathways. Food Funct. 2020;11(2):1798-1809. View abstract.
Lu K, Gray MA, Oliver C, et al. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol 2004;19:457-65. View abstract.
Lyon MR, Kapoor MP, Juneja LR. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial. Altern Med Rev. 2011;16(4):348-354. View abstract.
Miodownik C, Maayan R, Ratner Y, et al. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients. Clin Neuropharmacol 2011;34(4):155-60. View abstract.
Miyachi T, et al. Perioperative oral administration of cystine and theanine enhances recovery after distal gastrectomy: a prospective randomized trial. JPEN. 2013;37(3):384-391. View abstract.
Murakami S, Kurihara S, Koikawa N, et al. Effects of oral supplementation with cystine and theanine on the immune function of athletes in endurance exercise: randomized, double-blind, placebo-controlled trial. Biosci Biotechnol Biochem 2009;73(4):817-21. View abstract.
Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci 2008;11(4):193-8. View abstract.
Park SK, Jung IC, Lee WK, et al. A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study. J Med Food 2011;14(4):334-43. View abstract.
Ritsner MS, Miodownik C, Ratner Y, et al. L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study. J Clin Psychiatry 2011;72(1):34-42. View abstract.
Sadzuka Y, Sugiyama T, Miyagishima A, et al. The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin. Cancer Lett 1996;105:203-9. View abstract.
Sadzuka Y, Sugiyama T, Sonobe T. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol Lett 2000;114:155-62. View abstract.
Sadzuka Y, Sugiyama T, Sonobe T. Improvement of idarubicin induced antitumor activity and bone marrow suppression by theanine, a component of tea. Cancer Lett 2000;158:119-24. View abstract.
Sakato Y. The chemical constituents of tea: III. A new amide theanine. Nippon Nogei Kagakukaishi 1949;23:262-267.
Scheid L, et al. Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanin via capsules and green tea. J Nutr. 2012;142(12):2091-2096. View abstract.
Sugiyama T, Sadzuda Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett 1998;133:19-26. View abstract.
Sugiyama T, Sadzuka Y, Tanaka K, Sonobe T. Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin. Toxicol Lett 2000:121:89-96. View abstract.
Sugiyama T, Sadzuka Y. Combination of theanine with doxorobucin inhibits hepatic metastasis of M5076 ovarian sarcoma. Clin Cancer Res 1999;5:413-6. View abstract.
Tsuchiya T, Honda H, Oikawa M, et al. Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients. Int J Clin Oncol 2016;21(6):1085-90. View abstract.
Unno K, et al. Anti-stress effect of theanine on students during pharmacy practice: positive correlation among salivary a-amylase activity, trait anxiety and subjective stress. Pharmacol Biochem Behav. 2013;111:128-135. View abstract.
Williams J, Kellett J, Roach PD, et al. L-theanine as a functional food additive: its role in disease prevention and health promotion. Beverages 2016;2(2):13.
Williams J, McKune AJ, Georgousopoulou EN, et al. The effect of L-theanine incorporated in a functional food product (mango sorbet) on physiological responses in healthy males: a pilot randomised controlled trial. Foods 2020;9(3):371. View abstract.
Yokogoshi H, Kobayashi M. Hypotensive effect of gamma-glutamylethylamide in spontaneously hypertensive rats. Life Sci 1998;62:1065-8. View abstract.
Yokogoshi H, Mochizuki M, Saitoh K. Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechnol Biochem 1998;62:816-7. View abstract.
Yokozawa T, Dong E. Influence of green tea and its three major components upon low-density lipoprotein oxidation. Exp Toxicol Pathol 1997;49:329-35. View abstract.
Yokozawa T, Oura H, Nakagawa H, et al. Effects of a component of green tea on the proliferation of vascular smooth muscle cells. Biosci Biotechnol Biochem 1995;59:2134-6. View abstract.
Yoto A, Motoki M, Murao S, Yokogoshi H. Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses. J Physiol Anthropol. 2012;31:28. View abstract.
Zheng G, Sayama K, Okubo T, et al. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo 2004;18:55-62. View abstract.
Ad2) reference DMAE
Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 1999 Jun;22(6):273-80.
Jope RS, Jenden DJ. Dimethylaminoethanol (deanol) metabolism in rat brain and its effect on acetylcholine synthesis. J Pharmacol Exp Ther. 1979 Dec;211(3):472-9.
Millington WR, McCall AL, Wurtman RJ. Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline. Ann Neurol. 1978 Oct;4(4):302-6.
Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther. 1975 May;17(5):534-40.
Pfeiffer CC. Parasympathetic neurohumors. Possible precursors and effect on behavior. Int Rev Neurobiol. 1959;1:195-244.
Re O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Res Clin Exp. 1974 Nov;16(11):1238-42.
Ward D. Smart drugs and nutrients: how to improve your memory and increase your intelligence using the latest discoveries in neuroscience. Petaluma, CA: Smart Publications; 1992.
Danysz A, Smietanski J, Panek W. The influence of 2-dimethylaminoethanol (DMAE) on the mental and physical efficiency in man. Act Nerv Super (Praha). 1967 Nov;9(4):417.
Uhoda I, Faska N, Robert C, Cauwenbergh G, Pierard GE. Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. Skin Res Technol. 2002 Aug;8(3):164-7.
Dylewski DP, Nandy S, Nandy K. Effects of centrophenoxine on lipofuscin in the retinal pigment epithelium of old mice. Neurobiol Aging. 1983;4(1):89-95.
Riga S, Riga D. Effects of centrophenoxine on the lipofuscin pigments in the nervous system of old rats. Brain Res. 1974 Jun 7;72(2):265-75.
Zs-Nagy I. Pharmacological interventions against aging through the cell plasma membrane: a review of the experimental results obtained in animals and humans. Ann N Y Acad Sci. 2002 Apr;959:308-20.
Post JA, Bijvelt JJ, Verkleij AJ. Phosphatidylethanolamine and sarcolemmal damage during ischemia or metabolic inhibition of heart myocytes. Am J Physiol. 1995 Feb; 268(2 Pt 2): H773-80.
Casey DE, Denney D. Dimethylaminoethanol in tardive dyskinesia. N Engl J Med. 1974 Oct 10;291(15):797.
Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in Alzheimer’s disease. Am J Psychiatry. 1981 Jul;138(7):970-2.
Casey DE. Mood alterations during deanol therapy. Psychopharmacology (Berl). 1979 Apr 11;62(2):187-91.
Gebara E, Udry F, Sultan S, et al. Taurine increases hippocampal neurogenesis in aging mice. Stem Cell Res. 2015 May;14(3):369-79.
Rak K, Volker J, Jurgens L, et al. Neurotrophic effects of taurine on spiral ganglion neurons in vitro. Neuroreport. 2014 Nov 12;25(16):1250-4.
Prentice H, Modi JP, Wu JY. Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases. Oxid Med Cell Longev. 2015;2015:964518.
Li XJ, Li S, Li XQ, et al. [Effects of taurine on the ultrastructure and P2X7 receptor expression in brain following traumatic brain injury in rats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2012 Jul;28(4):301-3, 8.
Su Y, Fan W, Ma Z, et al. Taurine improves functional and histological outcomes and reduces inflammation in traumatic brain injury. Neuroscience. 2014 Apr 25;266:56-65.
Sun M, Zhao Y, Gu Y, et al. Protective effects of taurine against closed head injury in rats. J Neurotrauma. 2015 Jan 1;32(1):66-74.
Wang Q, Fan W, Cai Y, et al. Protective effects of taurine in traumatic brain injury via mitochondria and cerebral blood flow. Amino Acids. 2016 Sep;48(9):2169-77.
Zhao H, Qu J, Li Q, et al. Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. Amino Acids. 2018 Apr;50(3-4):439-51.
Zhu XY, Ma PS, Wu W, et al. Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats. Brain Res Bull. 2016 Jun;124:295-305.
Bae MA, Gao R, Kim SH, et al. Past Taurine Intake Has a Positive Effect on Present Cognitive Function in the Elderly. Adv Exp Med Biol. 2017;975 Pt 1:67-77.
Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, et al. The potential protective effects of taurine on coronary heart disease. Atherosclerosis. 2010 Jan;208(1):19-25.
Hansen SH, Andersen ML, Cornett C, et al. A role for taurine in mitochondrial function. J Biomed Sci. 2010 Aug 24;17 Suppl 1:S23.
Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids. 2012 Jun;42(6):2223-32.
Sun N, Youle RJ, Finkel T. The Mitochondrial Basis of Aging. Mol Cell. 2016 Mar 3;61(5):654-66.
Navarro A, Boveris A. Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease. Front Aging Neurosci. 2010;2.
Li XW, Gao HY, Liu J. The role of taurine in improving neural stem cells proliferation and differentiation. Nutr Neurosci. 2017 Sep;20(7):409-15.
Shivaraj MC, Marcy G, Low G, et al. Taurine induces proliferation of neural stem cells and synapse development in the developing mouse brain. PLoS One. 2012;7(8):e42935.
Leon R, Wu H, Jin Y, et al. Protective function of taurine in glutamate-induced apoptosis in cultured neurons. J Neurosci Res. 2009 Apr;87(5):1185-94.
Guan H, Qiu Z, Zhou X, et al. Protection of Taurine Against Impairment in Learning and Memory in Mice Exposed to Arsenic. Adv Exp Med Biol. 2017;975 Pt 1:255-69.
Zhang X, Wang X, Zhang J, et al. Effects of Taurine on Alterations of Neurobehavior and Neurodevelopment Key Proteins Expression in Infant Rats by Exposure to Hexabromocyclododecane. Adv Exp Med Biol. 2017;975 Pt 1:119-30.
Zhang Y, Li D, Li H, et al. Taurine Pretreatment Prevents Isoflurane-Induced Cognitive Impairment by Inhibiting ER Stress-Mediated Activation of Apoptosis Pathways in the Hippocampus in Aged Rats. Neurochem Res. 2016 Oct;41(10):2517-25.
Ames BN. Prolonging healthy aging: Longevity vitamins and proteins. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):10836-44.
Bouckenooghe T, Remacle C, Reusens B. Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care. 2006 Nov;9(6):728-33.
Hernandez-Benitez R, Vangipuram SD, Ramos-Mandujano G, et al. Taurine enhances the growth of neural precursors derived from fetal human brain and promotes neuronal specification. Dev Neurosci. 2013;35(1):40-9.
Liu J, Wang HW, Liu F, et al. Antenatal taurine improves neuronal regeneration in fetal rats with intrauterine growth restriction by inhibiting the Rho-ROCK signal pathway. Metab Brain Dis. 2015 Feb;30(1):67-73.
Pasantes-Morales H, Ramos-Mandujano G, Hernandez-Benitez R. Taurine enhances proliferation and promotes neuronal specification of murine and human neural stem/progenitor cells. Adv Exp Med Biol. 2015;803:457-72.
Fujikawa DG. The role of excitotoxic programmed necrosis in acute brain injury. Comput Struct Biotechnol J. 2015;13:212-21.
Wang R, Reddy PH. Role of Glutamate and NMDA Receptors in Alzheimer's Disease. J Alzheimers Dis. 2017;57(4):1041-8.
Lewerenz J, Maher P. Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? Front Neurosci. 2015;9:469.
Paula-Lima AC, De Felice FG, Brito-Moreira J, et al. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology. 2005 Dec;49(8):1140-8.
Jang H, Lee S, Choi SL, et al. Taurine Directly Binds to Oligomeric Amyloid-beta and Recovers Cognitive Deficits in Alzheim
er Model Mice. Adv Exp Med Biol. 2017;975 Pt 1:233-41.
Reeta KH, Singh D, Gupta YK. Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. Neurochem Int. 2017 Sep;108:146-56.
Chupel MU, Minuzzi LG, Furtado G, et al. Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women. Appl Physiol Nutr Metab. 2018 Jul;43(7):733-41.
Available at: http://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113. Accessed May 23, 2018.
Niu X, Zheng S, Liu H, et al. Protective effects of taurine against inflammation, apoptosis, and oxidative stress in brain injury. Mol Med Rep. 2018 Nov;18(5):4516-22.
Caletti G, Herrmann AP, Pulcinelli RR, et al. Taurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats. Amino Acids. 2018 Jan;50(1):95-104.
Available at: https://www.webmd.com/mental-health/what-is-dopamine. Accessed February 1, 2021.
Masato A, Plotegher N, Boassa D, et al. Impaired dopamine metabolism in Parkinson’s disease pathogenesis. Mol Neurodegener. 2019 Aug 20;14(1):35.
Knoll J. The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl. Mech Ageing Dev. 1988 Dec;46(1-3):237-62.
Knoll J. Deprenyl (selegiline): the history of its development and pharmacological action. Acta Neurol Scand Suppl. 1983;95:57-80.
Naoi M, Maruyama W. Cell death of dopamine neurons in aging and Parkinson’s disease. Mech Ageing Dev. 1999 Nov;111(2-3):175-88.
Heisters D. Parkinson’s: symptoms, treatments and research. Br J Nurs. 2011 May 13-26;20(9):548-54.
Knoll J. Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain. CNS Drug Rev. 2001 Fall;7(3):317-45.
Available at. Accessed November 10, 2015.
Saura J, Richards JG, Mahy N. Age-related changes on MAO in Bl/C57 mouse tissues: a quantitative radioautographic study. J Neural Transm Suppl. 1994;41:89-94.
Fowler CJ, Wiberg A, Oreland L, et al. The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm. 1980;49(1-2):1-20.
Kumar MJ, Andersen JK. Perspectives on MAO-B in aging and neurological disease: where do we go from here? Mol Neurobiol. 2004 Aug;30(1):77-89.
Kitani K, Kanai S, Carrillo MC, et al. (-)Deprenyl increases the life span as well as activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions in Fischer rats. Ann N Y Acad Sci. 1994 Jun 30;717:60-71.
Knoll J. Extension of life span of rats by long-term (-)deprenyl treatment. Mt Sinai J Med. 1988 Jan;55(1):67-74.
Jordens RG, Berry MD, Gillott C, et al. Prolongation of life in an experimental model of aging in Drosophila melanogaster. Neurochem Res. 1999 Feb;24(2):227-33.
Stoll S, Hafner U, Kranzlin B, et al. Chronic treatment of Syrian hamsters with low-dose selegiline increases life span in females but not males. Neurobiol Aging. 1997 Mar-Apr;18(2):205-11.
Kitani K, Miyasaka K, Kanai S, et al. Upregulation of antioxidant enzyme activities by deprenyl. Implications for life span extension. Ann N Y Acad Sci. 1996 Jun 15;786:391-409.
Ruehl WW, Entriken TL, Muggenburg BA, et al. Treatment with L-deprenyl prolongs life in elderly dogs. Life Sci. 1997;61(11):1037-44.
Freisleben HJ, Neeb A, Lehr F, et al. Influence of selegiline and lipoic acid on the life expectancy of immunosuppressed mice. Arzneimittelforschung. 1997 Jun;47(6):776-80.
Djukic M, Nau R, Sieber C. The ageing immune system. Dtsch Med Wochenschr. 2014 Oct;139(40):1987-90.
Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009 Nov;22(11):1041-50.
Available at. Accessed November 9, 2015.
Mazzio E, Deiab S, Park K, et al. High throughput screening to identify natural human monoamine oxidase B inhibitors. Phytother Res. 2013 Jun;27(6):818-28.
Zarmouh NO, Messeha SS, Elshami FM, et al. Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors. European J Med Plants. 2016 May;15(1).
Finberg JP, Rabey JM. Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology. Front Pharmacol. 2016;7:340.
Naoi M, Maruyama W, Inaba-Hasegawa K. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival. Curr Top Med Chem. 2012;12(20):2177-88.
Sun Y, Lenon GB, Yang AWH. Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review. Evid Based Complement Alternat Med. 2019;2019:7621929.
Xian YF, Lin ZX, Ip SP, et al. Comparison the neuropreotective effect of Cortex Phellodendri chinensis and Cortex Phellodendri amurensis against beta-amyloid-induced neurotoxicity in PC12 cells. Phytomedicine. 2013 Jan 15;20(2):187-93.
Kim Y, Jung I, Lee S. Effects of Phellodendron amurense extract on the Alzheimer’s disease model. Journal of Physiology & Pathology in Korean Medicine. 2005;19(1):130-8.
Available at: https://www.sciencedirect.com/topics/neuroscience/monoamine-oxidase-b. Accessed February 1, 2021.
Ad5) INOSITOL reference
Palatnik et al., “Double Blind, Controlled, Crossover Trial of Inositol Versus Fluvoxamine for the Treatment of Panic Disorder,” Journal of Clinical Psychopharmacology 21, no. 3 (2001): 335–339.
Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci. 2005 Apr;8(2):111-20.
2. Lau FC, Shukitt-Hale B, Joseph JA. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging. 2005 Dec;26 Suppl 1:128-32.
3. Available at: http://www.scientificamerican.com/article.cfm?id=your-brain-on-blueberries. Accessed April 5, 2012.
4. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999 Sep 15;19(18):8114-21.
5. Peng C, Zuo Y, Kwan KM, et al. Blueberry extract prolongs life span of Drosophila melanogaster. Exp Gerontol. 2012 Feb;47(2):170-8.
6. Wilson MA, Shukitt-Hale B, Kalt W, Ingram DK, Joseph JA, Wolkow CA. Blueberry polyphenols increase life span and thermotolerance in Caenorhabditis elegans. Aging Cell. 2006 Feb;5(1):59-68.
7. Aires DJ, Rockwell G, Wang T, et al. Potentiation of dietary restriction-induced life span extension by polyphenols. Biochim Biophys Acta. 2012 Apr;1822(4):522-6.
8. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005 Mar 17;352(11):1138-45.
9. Available at: http://www.nih.gov/news/pr/mar2005/nia-16.htm. Accessed April 5, 2012.
10. Prior RL, Wu X, Gu L, Hager TJ, Hager A, Howard LR. Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem. 2008 Feb 13;56(3):647-53.
11. Prior RL, Wu X, Gu L, et al. Purified berry anthocyanins but not whole berries normalize lipid parameters in mice fed an obesogenic high fat diet. Mol Nutr Food Res. 2009 Nov;53(11):1406-18.
12. Prior RL, S EW, T RR, Khanal RC, Wu X, Howard LR. Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J Agric Food Chem. 2010 Apr 14;58(7):3970-6.
13. Seymour EM, Tanone, II, Urcuyo-Llanes DE, et al. Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats. J Med Food. 2011 Dec;14(12):1511-8.
14. Liu Y, Wang D, Zhang D, et al. Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro. J Agric Food Chem. 2011 Nov 23;59(22):12254-63.
15. Johnson MH, Lucius A, Meyer T, de Mejia EG. Cultivar evaluation and effect of fermentation on antioxidant capacity and in vitro inhibition of alpha-amylase and alpha-glucosidase by highbush blueberry (Vaccinium corombosum). J Agric Food Chem. 2011 Aug 24;59(16):8923-30.
16. Moghe SS, Juma S, Imrhan V, Vijayagopal P. Effect of blueberry polyphenols on 3T3-F442A preadipocyte differentiation. J Med Food. 2012 Mar 8.
17. Vuong T, Benhaddou-Andaloussi A, Brault A, et al. Antiobesity and antidiabetic effects of biotransformed blueberry juice in KKA(y) mice. Int J Obes (Lond). 2009 Oct;33(10):1166-73.
18. Stull AJ, Cash KC, Johnson WD, Champagne CM, Cefalu WT. Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J Nutr. 2010 Oct;140(10):1764-8.
19. DeFuria J, Bennett G, Strissel KJ, et al. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr. 2009 Aug;139(8):1510-6.
20. Basu A, Du M, Leyva MJ, et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr. 2010 Sep;140(9):1582-7.
21. Stensvold D, Nauman J, Nilsen TI, Wisloff U, Slordahl SA, Vatten L. Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway). BMC Med. 2011;9:109.
22. Melzig MF, Funke I. Inhibitors of alpha-amylase from plants--a possibility to treat diabetes mellitus type II by phytotherapy? Wien Med Wochenschr. 2007;157(13-14):320-4.
23. Granfeldt YE, Bjorck IM. A bilberry drink with fermented oatmeal decreases postprandial insulin demand in young healthy adults. Nutr J. 2011;10:57.
24. Abidov M, Ramazanov A, Jimenez Del Rio M, Chkhikvishvili I. Effect of Blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteerswith diabetes type 2: double-blind, placebo controlled clinical study. Georgian Med News. 2006 Dec;(141):66-72.
25. Takikawa M, Inoue S, Horio F, Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr. 2010 Mar;140(3):527-33.
26. Wedick NM, Pan A, Cassidy A, et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr. 2012 Apr;95(4):925-33.
27. Basu A, Lyons TJ. Strawberries, blueberries, and cranberries in the metabolic syndrome: clinical perspectives. J Agric Food Chem. 2011 Nov 29.
28. Cassidy A, O’Reilly EJ, Kay C, et al. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011 Feb;93(2):338-47.
29. Shaughnessy KS, Boswall IA, Scanlan AP, Gottschall-Pass KT, Sweeney MI. Diets containing blueberry extract lower blood pressure in spontaneously hypertensive stroke-prone rats. Nutr Res. 2009 Feb;29(2):130-8.
30. Elks CM, Reed SD, Mariappan N, et al. A blueberry-enriched diet attenuates nephropathy in a rat model of hypertension via reduction in oxidative stress. PLoS One. 2011;6(9):e24028.
31. Kalea AZ, Clark K, Schuschke DA, Kristo AS, Klimis-Zacas DJ. Dietary enrichment with wild blueberries (Vaccinium angustifolium) affects the vascular reactivity in the aorta of young spontaneously hypertensive rats. J Nutr Biochem. 2010 Jan;21(1):14-22.
32. Kalea AZ, Clark K, Schuschke DA, Klimis-Zacas DJ. Vascular reactivity is affected by dietary consumption of wild blueberries in the Sprague-Dawley rat. J Med Food. 2009 Feb;12(1):21-8.
33. Kristo AS, Kalea AZ, Schuschke DA, Klimis-Zacas DJ. A wild blueberry-enriched diet (Vaccinium angustifolium) improves vascular tone in the adult spontaneously hypertensive rat. J Agric Food Chem. 2010 Nov 24;58(22):11600-5.
34. Wiseman W, Egan JM, Slemmer JE, et al. Feeding blueberry diets inhibits angiotensin II-converting enzyme (ACE) activity in spontaneously hypertensive stroke-prone rats. Can J Physiol Pharmacol. 2011 Jan;89(1):67-71.
35. Kalt W, Foote K, Fillmore SA, Lyon M, Van Lunen TA, McRae KB. Effect of blueberry feeding on plasma lipids in pigs. Br J Nutr. 2008 Jul;100(1):70-8.
36. Kim H, Bartley GE, Rimando AM, Yokoyama W. Hepatic gene expression related to lower plasma cholesterol in hamsters fed high-fat diets supplemented with blueberry peels and peel extract. J Agric Food Chem. 2010 Apr 14;58(7):3984-91.
37. Dunlap KL, Reynolds AJ, Duffy LK. Total antioxidant power in sled dogs supplemented with blueberries and the comparison of blood parameters associated with exercise. Comp Biochem Physiol A Mol Integr Physiol. 2006 Apr;143(4):429-34.
38. Hurst RD, Wells RW, Hurst SM, McGhie TK, Cooney JM, Jensen DJ. Blueberry fruit polyphenolics suppress oxidative stress-induced skeletal muscle cell damage in vitro. Mol Nutr Food Res. 2010 Mar;54(3):353-63.
39. McAnulty LS, Nieman DC, Dumke CL, et al. Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2.5 h of running. Appl Physiol Nutr Metab. 2011 Dec;36(6):976-84.
40. Available at: http://www.cdc.gov/nchs/fastats/heart.htm. Accessed March 30, 2012.
41. Xie C, Kang J, Chen JR, Nagarajan S, Badger TM, Wu X. Phenolic acids are in vivo atheroprotective compounds appearing in the serum of rats after blueberry consumption. J Agric Food Chem. 2011 Sep 28;59(18):10381-7.
42. Norton C, Kalea AZ, Harris PD, Klimis-Zacas DJ. Wild blueberry-rich diets affect the contractile machinery of the vascular smooth muscle in the Sprague-Dawley rat. J Med Food. 2005 Spring;8(1):8-13.
43. Auger C, Kim JH, Trinh S, Chataigneau T, Popken AM, Schini-Kerth VB. Fruit juice-induced endothelium-dependent relaxations in isolated porcine coronary arteries: evaluation of different fruit juices and purees and optimization of a red fruit juice blend. Food Funct. 2011 May;2(5):245-50.
44. Chang WC, Yu YM, Chiang SY, Tseng CY. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. Br J Nutr. 2008 Apr;99(4):709-14.
45. Wu X, Kang J, Xie C, et al. Dietary blueberries attenuate atherosclerosis in apolipoprotein E-deficient mice by upregulating antioxidant enzyme expression. J Nutr. 2010 Sep;140(9):1628-32.
46. Xie C, Kang J, Chen JR, et al. Lowbush blueberries inhibit scavenger receptors CD36 and SR-A expression and attenuate foam cell formation in ApoE-deficient mice. Food Funct. 2011 Oct;2(10):588-94.
47. Ahmet I, Spangler E, Shukitt-Hale B, et al. Blueberry-enriched diet protects rat heart from ischemic damage. PLoS One. 2009;4(6):e5954.
48. Ahmet I, Spangler E, Shukitt-Hale B, Joseph JA, Ingram DK, Talan M. Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats. PLoS One. 2009;4(11):e7975.
49. Available at: http://www.cdc.gov/nchs/fastats/cancer.htm. Accessed March 30, 2012.
50. Aiyer HS, Kichambare S, Gupta RC. Prevention of oxidative DNA damage by bioactive berry components. Nutr Cancer. 2008;60 Suppl 1:36-42.
51. Yi W, Fischer J, Krewer G, Akoh CC. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem. 2005 Sep 7;53(18):7320-9.
52. Adams LS, Phung S, Yee N, Seeram NP, Li L, Chen S. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2010 May 1;70(9):3594-605.
53. Nguyen V, Tang J, Oroudjev E, et al. Cytotoxic effects of bilberry extract on MCF7-GFP-tubulin breast cancer cells. J Med Food. 2010 Apr;13(2):278-85.
54. Boateng J, Verghese M, Shackelford L, et al. Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food Chem Toxicol. 2007 May;45(5):725-32.
55. Suh N, Paul S, Hao X, et al. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin Cancer Res. 2007 Jan 1;13(1):350-5.
56. Gordillo G, Fang H, Khanna S, Harper J, Phillips G, Sen CK. Oral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasm. Antioxid Redox Signal. 2009 Jan;11(1):47-58.
57. Liu Y, Song X, Zhang D, et al. Blueberry anthocyanins: protection against ageing and light-induced damage in retinal pigment epithelial cells. Br J Nutr. 2011 Oct 12:1-12.
58. Adams LS, Kanaya N, Phung S, Liu Z, Chen S. Whole blueberry powder modulates the growth and metastasis of MDA-MB-231 triple negative breast tumors in nude mice. J Nutr. 2011 Oct;141(10):1805-12.
59. Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RA. Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells. Biochem Cell Biol. 2005 Oct;83(5):637-43.
60. Seeram NP, Adams LS, Zhang Y, et al. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem. 2006 Dec 13;54(25):9329-39.
61. Srivastava A, Akoh CC, Fischer J, Krewer G. Effect of anthocyanin fractions from selected cultivars of Georgia-grown blueberries on apoptosis and phase II enzymes. J Agric Food Chem. 2007 Apr 18;55(8):3180-5.
62. Alosi JA, McDonald DE, Schneider JS, Privette AR, McFadden DW. Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res. 2010 Jun 15;161(2):195-201.
63. Zu XY, Zhang ZY, Zhang XW, Yoshioka M, Yang YN, Li J. Anthocyanins extracted from Chinese blueberry (Vaccinium uliginosum L.) and its anticancer effects on DLD-1 and COLO205 cells. Chin Med J (Engl). 2010 Oct;123(19):2714-9.
64. Schneider JG, Alosi JA, McDonald DE, McFadden DW. Pterostilbene inhibits lung cancer through induction of apoptosis. J Surg Res. 2010 Jun 1;161(1):18-22.
65. Available at: http://www.cdc.gov/nchs/fastats/alzheimr.htm. Accessed March 30, 2012.
66. Ramirez MR, Izquierdo I, do Carmo Bassols Raseira M, Zuanazzi JA, Barros D, Henriques AT. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res. 2005 Dec;52(6):457-62.
67. Papandreou MA, Dimakopoulou A, Linardaki ZI, et al. Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav Brain Res. 2009 Mar 17;198(2):352-8.
68. Duffy KB, Spangler EL, Devan BD, et al. A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats. Neurobiol Aging. 2008 Nov;29(11):1680-9.
69. Shukitt-Hale B, Lau FC, Carey AN, et al. Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutr Neurosci. 2008 Aug;11(4):172-82.
70. Joseph JA, Shukitt-Hale B, Willis LM. Grape juice, berries, and walnuts affect brain aging and behavior. J Nutr. 2009 Sep;139(9):1813S-7S.
71. Joseph JA, Carey A, Brewer GJ, Lau FC, Fisher DR. Dopamine and Abeta-induced stress signaling and decrements in Ca2+ buffering in primary neonatal hippocampal cells are antagonized by blueberry extract. J Alzheimers Dis. 2007 Jul;11(4):433-46.
72. Zhu Y, Bickford PC, Sanberg P, Giunta B, Tan J. Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase. Rejuvenation Res. 2008 Oct;11(5):891-901.
73. Brewer GJ, Torricelli JR, Lindsey AL, et al. Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract. J Nutr Biochem. 2010 Oct;21(10):991-8.
74. Fuentealba J, Dibarrart AJ, Fuentes-Fuentes MC, et al. Synaptic failure and adenosine triphosphate imbalance induced by amyloid-beta aggregates are prevented by blueberry-enriched polyphenols extract. J Neurosci Res. 2011 Sep;89(9):1499-508.
75. Wang Y, Chang CF, Chou J, et al. Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage. Exp Neurol. 2005 May;193(1):75-84.
76. Giacalone M, Di Sacco F, Traupe I, Topini R, Forfori F, Giunta F. Antioxidant and neuroprotective properties of blueberry polyphenols: a critical review. Nutr Neurosci. 2011 May;14(3):119-25.
77. Shukitt-Hale B, Lau FC, Joseph JA. Berry fruit supplementation and the aging brain. J Agric Food Chem. 2008 Feb 13;56(3):636-41.
78. Lau FC, Shukitt-Hale B, Joseph JA. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell Biochem. 2007;42:299-318.
79. Milbury PE, Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. J Agric Food Chem. 2010 Apr 14;58(7):3950-6.
80. McIntyre KL, Harris CS, Saleem A, et al. Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med. 2009 Feb;75(3):286-92.
81. de Rivera C, Shukitt-Hale B, Joseph JA, Mendelson JR. The effects of antioxidants in the senescent auditory cortex. Neurobiol Aging. 2006 Jul;27(7):1035-44.
82. Draelos ZD, Yatskayer M, Raab S, Oresajo C. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin. J Cosmet Dermatol. 2009 Jun;8(2):147-51.
83. Zhang J, Lazarenko OP, Blackburn ML, et al. Feeding blueberry diets in early life prevent senescence of osteoblasts and bone loss in ovariectomized adult female rats. PLoS One. 2011;6(9):e24486.
Nutr Rev. 1994;52(10):327-39.
ad9) vitamíny skupiny B referenece
International journal of clinical practice. 2011;65(6):684-690.
Neurochemical research. 2015;40(2):353-361.
J Lab Clin Med. 1975;86(1):77-90.
National Institutes of Health. Office of Dietary supplements. Riboflavin: Fact Sheet for Health Professionals. Accessed Jun. 17, 2019. https://ods.od.nih.gov/factsheets/Riboflavin-HealthProfessional/
J Lipid Res. 2019;60(4):741-746.
Chemico-Biological Interactions. 2006;163(1):94-112.
Altern Med Rev. 2011;16(3):263-74.
The American Journal of Clinical Nutrition. 2007;86(5):1563S-1568S.
Molecules. 2009;14(1):329-351.
Advances in Nutrition. 2012;3(2):213-214.
Clinical pharmacokinetics. 2010;49(8):535-548.
J Inherit Metab Dis. 2018
J Pediatr. 2018;202:315-319.e2.
Mayo Clin Proc Innov Qual Outcomes. 2019;3(2):200-214.
J Cell Biochem. 2006;97(2):252-60.
Curr Biol. 1998;8(16):R557-9.
Bizzarri M, Fuso A, Dinicola S, Cucina A, Bevilacqua A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opinion on Drug Metabolism and Toxicology 2016. 12 1181–1196.
Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006. 443 651–657.
Paul C, Laganà AS, Maniglio P, Triolo O, Brady DM. Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecological Endocrinology 2016. 32 431–438.
Giordano D, Corrado F, Santamaria A, Quattrone S, Pintaudi B, Di Benedetto A, D’Anna R. Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. Menopause 2011. 18 102–104.
Santamaria A, Giordano D, Corrado F, Pintaudi B, Interdonato ML, Di Vieste G, Di Benedetto A, D’Anna R. One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric 2012. 15 490–495.
Celentano C, Matarrelli B, Mattei PA, Pavone G, Vitacolonna E, Liberati M. Myo-inositol supplementation to prevent gestational diabetes mellitus.
D’Anna R, Di Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, Neri I, Pintaudi B, Corrado F, Facchinetti F. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial.
D’Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, Corrado F, Di Benedetto A. Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, D’Anna R, Neri I, Facchinetti F. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. Journal of Maternal-Fetal and Neonatal Medicine 2015. 19 1–4.
Zheng X, Liu Z, Zhang Y, Lin Y, Song J, Zheng L, Lin S. Relationship between myo-inositol supplementary and gestational diabetes mellitus: a meta-analysis. Medicine 2015. 94 e1604
Karimipour DJ, Rittié L, Hammerberg C, et al. Molecular analysis of aggressive microdermabrasion in photoaged skin. Archives of Dermatology. 2009;145(10):1114–1122.
El-Domyati M, El-Ammawi TS, Moawad O, et al. Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. International Journal of Dermatology. 2012;51(8):913–919.
Amin SP, Phelps RG, Goldberg DJ. Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatologic Surgery. 2006;32(12):1467–1472.
Savoia A, Landi S, Baldi A. A new minimally invasive mesotherapy technique for facial rejuvenation. Dermatology and Therapy. 2013;3:83–93.
Sommerfeld B. Randomised, placebo-controlled, double-blind, split-face study on the clinical efficacy of Tricutan on skin firmness. Phytomedicine. 2007;14(11):711–715.
Uhoda I, Faska N, Robert C, Cauwenbergh G, Piérard GE. Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. Skin Research and Technology. 2002;8(3):164–167.
Grossman RM, Gisoldi EM, Cole AC. Long term Safety and efficacy evaluation of a new skin firming technology: dimethylaminoethanol. Proceedings of the 60th Annual Meeting of the Academy of Dermatology; February 2002; New Orleans, La, USA.
Wang D, Liu M, Cao J, et al. Effect of Colla corii asini (E'jiao) on D-galactose induced aging mice. Biological and Pharmaceutical Bulletin. 2012;35(12):2128–2132.
Pei XR, Yang RY, Zhang ZF, et al. Effects of marine collagen peptide on delaying the skin aging. Zhong Hua Y Fang Yi Xue Za Zhi. 2008;42(4):235–238.
Liang J, Pei X, Zhang Z, et al. The protective effects of long-term oral administration of marine hydrolysate from chum salmon on in the chronological aging Sprague-Dawley male rats. Journal of Food Science. 2010;75(8):H230–H238.
d.Plevin, Ch. Galletly.: The neuropsychiatric effects of vitamin C deficiency: a systematic review.BMC Psychiatry volume 20, Article number: 315 (2020)
Victor M, Adams R, Collins GH. The Wernicke-Korsakoff Syndrome. F.A. Davis; Philadelphia: 1989.
Williams RD, et al. Observations on induced thiamine (vitamin b1) deficiency in man. Archives of Internal Medicine. 1940;66:785–799.
Kopelman M. Frontal dysfunction and memory deficits in the alcoholic Korsakoff syndrome and Alzheimer-Type Dementia. Brain. 1991;114:117–137.
Dubois B, et al. Revising the definition of Alzheimer’s disease: a new lexicon. The Lancet Neurology. 2010;9:1118–1127.
Sperling RA, et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia. 2011;7:280–292.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412771/
Spies T.D., Bean W.B., Stone R.E. The Treatment of Subclinical and Classic Pellagra Use of Nicotinic Acid, Nicotinic Acid Amide and Sodium Nicotinate, with Special Reference to the Vasodilator Action and the Effect on Mental Symptoms. JAMA. 1938;111:584–592. doi: 10.1001/jama.1938.02790330004002.
Magni G., Amici A., Emanuelli M., Orsomando G., Raffaelli N., Ruggieri S. Enzymology of NAD+ Homeostasis in Man. Cell. Mol. Life Sci. 2004;61:19–34. doi: 10.1007/s00018-003-3161-1.
Goodman R.P., Calvo S.E., Mootha V.K. Spatiotemporal Compartmentalization of Hepatic NADH and NADPH Metabolism. J. Biol. Chem. 2018;293:7508–7516. doi: 10.1074/jbc.TM117.000258.
Kirkland J.B. Niacin Status, NAD Distribution and ADP-Ribose Metabolism. Curr. Pharm. Des. 2009;15:3–11. doi: 10.2174/138161209787185823.
Nikiforov A., Kulikova V., Ziegler M. The Human NAD Metabolome: Functions, Metabolism and Compartmentalization. Crit. Rev. Biochem. Mol. Biol. 2015;50:284–297.
McCormick D. Vitamin B6. In: Bowman B, Russell R, eds. Present Knowledge in Nutrition. 9th ed. Washington, DC: International Life Sciences Institute; 2006.
Mackey A, Davis S, Gregory J. Vitamin B6. In: Shils M, Shike M, Ross A, Caballero B, Cousins R, eds. Modern Nutrition in Health and Disease. 10th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2005.
Subar AF, Krebs-Smith SM, Cook A, Kahle LL. Dietary sources of nutrients among US adults, 1989 to 1991. J Am Diet Assoc 1998;98:537-47.
Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I–Folate, Vitamin B12, Vitamin B6. J Matern Fetal Neonatal Med 2010;23:1323-43.
Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011;141:261-6.
Scott J.M. Bioavailability of vitamin B12. Eur. J. Clin. Nutr. 1997;51:S49–53.
Gibson R.S. Principles of Nutritional Assessment. 2nd. Oxford University Press; New York, NY, USA: 2005.
Food and Nutrition Board, authors; National Research Council, editor. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. National Academy Press; Washington, DC, USA: 1998. Institute of Medicine, Vitamin B12; pp. 306–356.
Carmel R. Mild transcobalamin I (haptocorrin) deficiency and low serum cobalamin concentrations. Clin. Chem. 2003;49:1367–1374.
Carmel R., Green R., Rosenblatt D.S., Watkins D. Update on cobalamin, folate, and homocystein. Hematology Am. Soc. Hematol. Educ. Program. 2003:62–81.
Niki E, Traber MG. A history of vitamin E. Ann Nutr Metab. 2012;61:207–12.
Zingg JM. Vitamin E: An overview of major research directions. Mol Aspects Med. 2007;28:400–422.
Chow CK. Distribution of tocopherols in human plasma and red blood cells. Am J Clin Nutr. 1975;28:756–60.
Drotleff AM, Ternes W. Determination of RS,E/Z-tocotrienols by HPLC. J Chomatogr A. 2001;909:215–23.
Zingg JM. Molecular and cellular activities of vitamin E analogues. Mini Rev Med Chem. 2007;7:543–58.
Ball GFM. Vitamins in Foods: Analysis, bioavailability, and stability. Boca Raton, Florida: CRC Press; 2006. pp. 119–36.